Because P-gp is a major cellular pump that removes foreign substances and delivers them into the blood, body fluids, and the intestinal lumen19, the focus of the present study was to explore a novel injectable formulation to facilitate the delivery of PTX through co-administration of a P-gp inhibitor for the treatment of glioma. The gene discussed is PGP; the disease is glioma.